TAR RNA binding properties and relative transactivation activities of human immunodeficiency virus type 1 and 2 Tat proteins.

Por Rhim, H, Rice, A P
Publicado em 1993

Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins.

Por Rice, A P, Carlotti, F
Publicado em 1990

Mutational analysis of the conserved cysteine-rich region of the human immunodeficiency virus type 1 Tat protein.

Por Rice, A P, Carlotti, F
Publicado em 1990

Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.

Por Rhim, H, Rice, A P
Publicado em 1994

Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression.

Por Gold, M O, Rice, A P
Publicado em 1998

Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II:...

Por Herrmann, C H, Rice, A P
Publicado em 1995

Vaccinia virus induces cellular mRNA degradation.

Por Rice, A P, Roberts, B E
Publicado em 1983

Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells.

Por Rice, A P, Kerr, I M
Publicado em 1984

Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein.

Por Rice, A P, Mathews, M B
Publicado em 1988

The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.

Por Yang, X, Herrmann, C H, Rice, A P
Publicado em 1996

Viral transactivators specifically target distinct cellular protein kinases that phosphorylate the RNA polymerase II C-terminal domain.

Por Herrmann, C H, Gold, M O, Rice, A P
Publicado em 1996

2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.

Por Rice, A P, Roberts, W K, Kerr, I M
Publicado em 1984

Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase.

Por Gunnery, S, Rice, A P, Robertson, H D, Mathews, M B
Publicado em 1990

Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells.

Por Rice, A P, Duncan, R, Hershey, J W, Kerr, I M
Publicado em 1985

Novel 2',5'-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells.

Por Rice, A P, Kerr, S M, Roberts, W K, Brown, R E, Kerr, I M
Publicado em 1985

Viral transactivators E1A and VP16 interact with a large complex that is associated with CTD kinase activity and contains CDK8.

Por Gold, M O, Tassan, J P, Nigg, E A, Rice, A P, Herrmann, C H
Publicado em 1996